{"disease":{"id":"vasovagal-syncope-vvs","name":"vasovagal syncope vvs"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07459478","title":"Assesment of the Clinical Benefit of Provocation on Tilt-table in SYNCope Patients, TiltSYNC-trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":238,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT05755737","title":"A Proof of Principle Study of Ondansetron for the Prevention of Vasovagal Syncope: The Eleventh Prevention of Syncope Trial (POST11)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT07030218","title":"A Warning Red Flag Classification System to Predict Risk of Vasovagal Syncope During Office Hysteroscopy","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":46,"lead_sponsor_name":"Tanvir Hospital","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}